Advertisement

Metabolic Aspects of Renal Stone Disease

  • Hibbard E. Williams

Abstract

The problems of diagnosis and treatment of renal stone disease remain much the same as they have for the past several years. The most important of these is the question of basic pathogenetic mechanisms in stone formation and growth, particularly in the so-called “idiopathic stone-formers.” Solutions to this problem are slowly emerging and are essential for the development of rational and effective treatment programs. The causes of the common idiopathic hypercalciuria syndrome continue to be debated throughout the world, and some consensus is beginning to develop. The importance of urate in the nucleation of calcium oxalate stones and the role of relatively minor changes in urinary oxalate excretion in the development of these stones also remain as key issues in our understanding of recurrent nephrolithiasis.

Keywords

Thiola Myeloma Adenine Purine Ileal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cartier, P., Harriet, M., and Hamburger, J., 1974, Une nouvelle maladie métabolique: Le défecit complete en adénine-phosphoribosyl-transférase avec lithiases de 2,8-dihydroxyadénine, C. R. Acad. Sci. 279:883.Google Scholar
  2. Coe, F. L., Canterbury, J. M., Firpo, J. O., and Reiss, E., 1973, Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria, J. Clin. Invest. 52:134.PubMedCrossRefGoogle Scholar
  3. Coe, F. L., and Kavalach, A. G., 1974, Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis, N. Engl. J. Med. 291:1344.PubMedCrossRefGoogle Scholar
  4. Coe, F. L., and Raisen, L., 1973, Allopurinol treatment of uric-acid disorders in calcium-stone formers, Lancet 1:129.PubMedCrossRefGoogle Scholar
  5. Cryer, P. E., Garber, A. J., Hoffstein, P., Lucas, B., and Wise, L., 1975, Renal failure after small intestinal bypass for obesity, Arch. Intern. Med. 135:1610.PubMedCrossRefGoogle Scholar
  6. Earnest, D., Campbell, J., Hunt, T. K., and Naughton, J., 1977, Progressive renal failure with hyperoxaluria: a new complication of jejunoileal bypass, Gastroenterology 72:1054.Google Scholar
  7. Griffith, D. P., Gibson, J. R., Clinton, C. W., and Musher, D. M., 1976, Acetohy-droxamic acid: Initial investigations in man, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 545–548, Plenum Press, New York.CrossRefGoogle Scholar
  8. Griffith, D. P., and Musher, D. M., 1976, Urease: Principal cause of infection stones, in Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 451–454, Plenum Press, New York.CrossRefGoogle Scholar
  9. Muldowney, F. P., Freaney, R., Spillane, E. A., and O’Donoghue, P., 1973, Ionised calcium levels in “Normocalcaemic” hyperparathyroidism, Ir. J. Med. Sci. 14:223.CrossRefGoogle Scholar
  10. Nancollas, G. H., 1976, The kinetics of crystal growth and renal stone formation, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 5–23, Plenum Press, New York.CrossRefGoogle Scholar
  11. Nordin, B. E. C., Peacock, M., and Marchall, D. H., 1976, Calcium excretion and hypercalciuria, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 101–116, Plenum Press, New York.CrossRefGoogle Scholar
  12. Pak, C. Y. C., 1976, Idiopathic renal lithiasis: New developments in evaluation and treatment, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 213–224, Plenum Press, New York.CrossRefGoogle Scholar
  13. Pak, C. Y. C., 1977, Physicochemical and clinical aspects of nephrolithiasis, in: International Colloquium on Renal Lithiasis Gainesville, Florida, January 1976 (in press).Google Scholar
  14. Proceedings of the International Symposium on Bladder Stone Disease in Southeast Asia, 1977, Washington, D.C., April 1976 (in press).Google Scholar
  15. Remien, A., Kallistratos, G., and Burchardt, P., 1975, Treatment of cystinuria with Thiola (α-mercaptopropionyl glycine), Eur. Urol. 1:227.PubMedGoogle Scholar
  16. Robertson, W. G., 1976, Physical chemical aspects of calcium stone-formation in the urinary tract, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 25–39, Plenum Press, New York.CrossRefGoogle Scholar
  17. Robertson, W. G., Peacock, M., and Nordin, B. E. C., 1972, Measurement of activity products in urine from stone-formers and normal subjects, in: UrolithiasisPhysical Aspects (B. Finlayson, L. L. Hench, and L. H. Smith, eds.), pp. 79–95, National Academy of Sciences, Washington, D.C.Google Scholar
  18. Robertson, W. G., Knowles, F., and Peacock, M., 1976, Urinary acid mucopolysaccharide inhibitors of calcium oxalate crstallization, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 331–334, Plenum Press, New York.CrossRefGoogle Scholar
  19. Seegmiller, J. E., 1976, Genetic defects in human purine metabolism leading to urolithiasis, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 147–154, Plenum Press, New York.CrossRefGoogle Scholar
  20. Simmonds, H. A., Van Acker, K. J., Cameron, J. S., and Snedden, W., 1976, A new cause of urinary calculi: 2,8-Dihydroxyadenine stones in supposed “uric acid” crystalluria, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 517–521, Plenum Press, New York.CrossRefGoogle Scholar
  21. Smith, L. H., 1976, Application of physical, chemical, and metabolic factors to the management of urolithiasis, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 199–211, Plenum Press, New York.CrossRefGoogle Scholar
  22. Spector, A. R., Gray, A., and Prien, E. L., Jr., 1976, Kidney stone matrix: Difference in acidic protein composition, Invest. Urol. 13:387.PubMedGoogle Scholar
  23. Van Reen, R., 1976, Idiopathic urinary bladder stone disease, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 569–572, Plenum Press, New York.CrossRefGoogle Scholar
  24. Williams, H. E., 1976a, Metabolic aspects of renal stone disease, in: The Year in Metabolism 1975–1976 (N. Freinkel, ed.), pp. 299–316, Plenum Press, New York.CrossRefGoogle Scholar
  25. Williams, H. E., 1976b, Oxalic acid: Absorption, excretion and metabolism, in: Urolithiasis Research (H. Fleisch, W. G. Robertson, L. H. Smith, and W. Vahlensieck, eds.), pp. 181–188, Plenum Press, New York.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Hibbard E. Williams
    • 1
    • 2
  1. 1.Medical ServiceSan Francisco General Hospital Medical CenterSan FranciscoUSA
  2. 2.Department of MedicineUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations